Rheumatology Advisor
Rheumtaology Advisor offers featured news, research updates, and treatment guidelines to Rheumatology healthcare professionals.
American College of Rheumatology Releases Updated Guidelines …
Jun 18, 2021 · The American College of Rheumatology (ACR) recently released updated guidelines for the pharmacologic management of rheumatoid arthritis (RA). The full report has been published simultaneously in Arthritis Care & Research and Arthritis & Rheumatology.. Overall, the updated guidelines include treatment with disease-modifying antirheumatic drugs (DMARDs), including biologic DMARDs (bDMARDs) and ...
2022 ACR/AAHKS Guidelines for Management of
Apr 6, 2022 · References. American College of Rheumatology & American Association of Hip and Knee Surgeons. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty: guideline summary.
Patients With SARDs Face Increased Risks for Adverse Events With …
1 day ago · Patients with systemic autoimmune rheumatic diseases (SARDs) face higher risks for adverse events (AEs) when using sodium-glucose cotransporter-2 (SGLT2) inhibitors, compared against individuals without these conditions, according to study results published in Clinical Rheumatology.. As patients with SARDs are often excluded from certain clinical trials due to immunosuppressive therapies and ...
Rheumatologists Discuss Management of Muscle Loss in …
Oct 14, 2022 · Muscle weakness — also known as rheumatoid cachexia or rheumatoid sarcopenia — is a common occurrence among patients with RA. Credit: Getty Images Rheumatologists, Joshua Baker, MD, Brian Andonian, MD, and Ira Khanna, MD, discuss the occurrence and management of muscle weakness and …
Ixekizumab Reduces Nighttime Spinal Pain, Enhances Long-Term …
1 day ago · Patients with radiographic axial spondyloarthritis (r-axSpA) report significant reductions in nighttime spinal pain and long-term health improvements following treatment with ixekizumab, according to results of a post-hoc analysis published in Seminars in Arthritis & Rheumatism.. Radiographic axial spondyloarthritis is a chronic inflammatory condition that profoundly affects patients’ lives ...
Overview of Latest Treatment Strategies for Active Psoriatic …
An abstract presented at ACR 2023 reported on the results of the interleukin (IL)-17 inhibitor bimekizumab among patients with active PsA from the BE OPTIMAL (ClinicalTrials.gov identifier: NCT03895203) and BE COMPLETE trials (ClinicalTrials.gov identifier: NCT03896581). 1 Using these data, what is the effect of bimekizumab vs placebo on patient-reported outcomes, including pain and fatigue ...
JAK Inhibitors Show Superior Pain Reduction in Rheumatoid Arthritis
Nov 6, 2024 · Janus kinase (JAK) inhibitors demonstrate a slight advantage for reducing pain among patients with rheumatoid arthritis (RA) when compared with tumor necrosis factor (TNF) inhibitors, particularly in clinical practice settings, according to study results published in Arthritis & Rheumatology.. Researchers in Sweden performed an observational cohort study to compare the effectiveness of JAK ...
Management of Rheumatic Disease: The Interface
Jan 29, 2016 · Rheumatic diseases comprise a constellation of more than 100 discrete disorders primarily affecting the joints and connective tissues, and is a leading cause of work disability and activity limitation in the United States.
Updated EULAR Recommendations for Rheumatoid Arthritis …
Feb 13, 2020 · Based on emerging new evidence and expert consensus, an international task force put together by the European League Against Rheumatism (EULAR) released updated recommendations for the management of rheumatoid arthritis (RA) with synthetic and biologic disease-modifying antirheumatic drugs (DMARDs).